UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003454 |
|---|---|
| Receipt number | R000004175 |
| Scientific Title | Phase II study of alternate-day administrations of S-1 as 2nd-line treatment in patients with metastatic and locally advanced pancreatic cancer |
| Date of disclosure of the study information | 2010/04/06 |
| Last modified on | 2019/10/14 13:16:02 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/04/06 14:17:55 | ||
| 2 | Update | 2019/10/14 13:13:09 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Organization Division name Address Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization Organization Address Address Tel |
|
| 3 | Update | 2019/10/14 13:16:02 | Recruitment status Date of IRB |
